arimoclomol has been researched along with Inclusion Body Myopathy, Sporadic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amato, AA; Barohn, RJ; Blaettler, T; Bonefeld, K; Carstensen, TD; Ciafaloni, E; Dimachkie, MM; Freimer, M; Gibson, SB; Hanna, MG; Heim, AJ; Herbelin, L; Jones, SM; Jørgensen, AN; Levine, TD; Lloyd, TE; Machado, PM; McDermott, MP; Mozaffar, T; Phonekeo, K; Rosholm, A; Shaibani, AI; Sundgreen, C; Wicklund, M | 1 |
| Ahmed, M; Barohn, RJ; Brady, S; Collinson, L; Dimachkie, MM; Gallagher, P; Greensmith, L; Hanna, MG; He, J; Herbelin, L; Holton, JL; Kalmar, B; Lu, CH; Machado, PM; McVey, AL; Miller, A; Noel, J; Parton, M; Pasnoor, M; Samandouras, G; Schiavo, G; Sethi, H; Spicer, C; Statland, J; Taylor, JP; Wang, Y; Weston, A | 1 |
1 trial(s) available for arimoclomol and Inclusion Body Myopathy, Sporadic
| Article | Year |
|---|---|
Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial.
Topics: Adult; Animals; Disease Progression; Double-Blind Method; Female; Humans; Male; Mice; Myositis, Inclusion Body; Pilot Projects; United States | 2023 |
1 other study(ies) available for arimoclomol and Inclusion Body Myopathy, Sporadic
| Article | Year |
|---|---|
Targeting protein homeostasis in sporadic inclusion body myositis.
Topics: Adenosine Triphosphatases; Amyloid beta-Peptides; Animals; Cell Cycle Proteins; Cell Survival; Cells, Cultured; Clinical Trials as Topic; Endoplasmic Reticulum Stress; Homeostasis; HSP70 Heat-Shock Proteins; Humans; Hydroxylamines; Inflammation Mediators; Mice; Muscle Contraction; Muscle Strength; Mutation; Myoblasts; Myositis, Inclusion Body; Proteins; Rats; Treatment Outcome; Valosin Containing Protein | 2016 |